Citation:Nye L, Rademaker A, Gradishar WJ 2017

From Cancer Guidelines Wiki

Citation


Nye L, Rademaker A, Gradishar WJ. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era. Clin Breast Cancer 2017 Jul;17(4):e185-e189 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28185739.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Pregnancy and cancer recurrenceDr Sally Reidcompleted
Interruption of hormone therapyDr Jessica Harriscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In cancer survivors, does pregnancy increase the risk or delay the diagnosis of cancer recurrence?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In cancer survivors, does pregnancy increase the risk or delay the diagnosis of cancer recurrence?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:In breast cancer patients who want to become pregnant, does interrupting adjuvant hormone therapy to conceive increase the risk of cancer recurrence?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In breast cancer patients who want to become pregnant, does interrupting adjuvant hormone therapy to conceive increase the risk of cancer recurrence?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Interrupting hormone therapy to conceive